Will orthopaedic robotics become more affordable?

Robotic orthopaedic surgery is rapidly evolving, driven by precision, personalisation and technological synergy with AI/augmented reality (AR). While robotic surgery in orthopaedics involves significant upfront costs, studies suggest long-term economic benefits due to improved outcomes and reduced complications. At the 2025 annual meeting of the American Academy of Orthopedic Surgeons (AAOS), held from 10 March to 14 March in San Diego, California, more device makers presented the newest generation of orthopaedic robots, which will reduce the cost of robotic-assist orthopaedic surgery

According to GlobalData’s Global Brand Pricing product, the average cost of an orthopaedic robotic system varies from $554,000 to more than $1 million. Annual service costs are around 10% of the system. The price of orthopaedic robotic systems is expected to decline due to market competition, technological innovation and economies of scale. Portable systems such as Smith & Nephew’s CORI and Think Surgical’s TMINI are already reducing costs, while startups and emerging markets drive competition with affordable alternatives. Companies such as Think Surgical and Korea-based Curexo have developed robotic systems that are compatible with implants from other manufacturers, which could further reduce the robotic procedure cost by choosing affordable knee or hip implants.

Mass adoption — projected to grow the global market to $13 billion by 2030 — will lower manufacturing costs, and subscription-based pricing models could replace upfront fees. Robotic orthopaedic surgery, while initially expensive due to high upfront costs for systems and ongoing maintenance, demonstrates long-term cost-effectiveness. Enhanced precision in implant placement and alignment also lowers the need for costly revisions. Additionally, streamlined workflows and value-based care models further improve economic viability by prioritising outcomes over volume. Regulatory support and insurer reimbursement for proven outcomes will accelerate affordability. However, challenges such as surgeon training costs and persistent software upgrade expenses may delay accessibility in resource-limited settings.

Up to 2029, GlobalData expects prices to drop 20% to 30% as compact systems and competition expand. In the long term, robotics could become standard care, with costs nearing those of conventional tools due to AI-driven automation and scaled production. While affordability hinges on innovative pricing and healthcare policies, the trajectory suggests robotic surgery will transition from a premium option to a broadly accessible, cost-effective standard in orthopaedics.